We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
- Authors
Fumoleau, P; Delgado, F M; Delozier, T; Monnier, A; Gil Delgado, M A; Kerbrat, P; Garcia-Giralt, E; Keiling, R; Namer, M; Closon, M T
- Abstract
This study investigated the therapeutic effects of single-agent intravenous (IV) weekly Navelbine (vinorelbine or 5'-nor-anhydro-vinblastine; Pierre Fabre Médicament, Boulogne, France), a semisynthetic vinca alkaloid, in women who had received no prior chemotherapy for locally advanced or metastatic breast cancer.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Vol 11, Issue 7, p1245
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1993.11.7.1245